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Summary 
 Limited information is currently available about the incidence and prevalence of Fetal 
Alcohol Spectrum Disorders (FASD) in Australia and internationally. This lack of data 
reflects the low level of awareness by clinicians of FASD conditions, the complexity of 
diagnosis and the absence of nationally agreed and consistent diagnostic criteria and 
definitions.  
 The quality of information available in existing data collections is variable and 
incomplete for ascertaining Fetal Alcohol Syndrome cases. There is no information 
available on other disorders in the spectrum.  
 Regular surveillance and monitoring have been identified as priorities for determining 
incidence and prevalence. It is considered that the most feasible medium-term model for 
FASD data collection is to enhance the scope of national and jurisdictional congenital 
anomalies collections to include FASD.  
 In the short term, a program of data development regarding FASD and the use of record 
linkage to monitor ‘statistical FASD’ will provide more complete data than are available 
now. A national data repository on FASD would enable appropriate resources and 
services to be delivered to those affected (and their families), as well as providing 
support to researchers and clinicians. 
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1 Introduction 
Fetal Alcohol Spectrum Disorders (FASD) is emerging as a public health issue in Australia. 
This group of disorders has been cited as the most common preventable cause of intellectual 
impairment among children (O’Leary 2004). 
An early and accurate FASD diagnosis can help to improve the outcomes and quality of life 
for those affected and their families; however, this is difficult without an agreed FASD 
diagnostic instrument. Support and services for FASD-affected children could be provided 
by including FASD in the List of Recognised Disabilities, and in the Better Start for Children 
with a Disability initiative (FaHCSIA 2013). However, services are available according to the 
level of functional impairment and do not depend on a formal diagnosis of FASD. 
Purpose of this project 
Health-care providers and policy makers need accurate and timely data in a useable format 
to monitor and prevent FASD. There is widespread concern about the lack of information on 
FASD and the impact this has on health-care planners and providers in managing the 
problem in a timely and effective way (Bower et al. 2000; Elliott et al. 2006; May et al. 2009; 
Mutch et al. 2009; O’Leary 2004; Payne et al. 2005; Premji & Semenic 2009).  
The main purpose of this project was to identify ways to facilitate the collection and 
reporting of FASD-related information in Australia. The use of existing data collections and 
data sets to develop an ongoing reporting system was examined. Opportunities for data 
development and options for storage of the data collection were also identified.  
Project scope and methodology 
This project looked at four interrelated issues for collecting FASD information in Australia: 
• current status and reliability of the epidemiological information 
• FASD-related contents of various administrative and non-administrative collections 
• methods to enhance, link and better use existing data collections 
• structure and format of the new potential data set or collection. 
The project methodology involved: 
• reviewing recent information on the epidemiology of FASD (including 
incidence/prevalence, sociodemographics, maternal alcohol consumption and specific 
clinical criteria) 
• reviewing current collections; identifying data gaps and opportunities and strategies to 
enhance, expand or modify these collections to generate suitable information related to 
FASD with input from experts and various stakeholders 
• developing models to effectively use various data collections, including through record 
linkage and risk factor–disease association studies, and exploring mechanisms for new 
data development. 
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FASD epidemiology 
‘FASD’ is an umbrella term that encompasses four conditions that are considered to be the 
result of exposure of an unborn baby to alcohol during pregnancy. These disorders are 
separated into Fetal Alcohol Syndrome (FAS), partial FAS (pFAS), alcohol-related 
neuro-developmental disorders (ARND) and alcohol-related birth defects (ARBD). These 
conditions represent a continuum of alcohol effect during fetal life on the structural and 
functional development of the brain, structural development of the face, and effects on 
growth and development generally (Figure 1.1).  
 
Notes 
 1. Palpebral fissures are the opening between the eyelids. 
 2. The philtrum is the vertical groove in the middle area of the upper lip. 
Figure 1.1: Continuum of FASD features and neuro-developmental abnormalities  
The available data related to FASD are incomplete because of the general lack of recognition 
of FASD by clinicians and by poor or delayed diagnosis. The poor quality of these data limits 
their use in monitoring, preventing and planning treatment for these disorders. There is 
limited information about the prevalence of FASD in Australia, and the available statistics 
relate almost exclusively to FAS. There are currently no national population estimates of the 
prevalence of FAS. In Western Australia, FAS prevalence has been estimated as 0.18 per 
1,000 children (Bower et al. 2000); in the Northern Territory, 0.68 per 1,000 children (Harris & 
Bucens 2003); and in Victoria, 0.01 to 0.03 per 1,000 children (Allen et al. 2007). For 
Indigenous children, the reported prevalence of FAS was 2 to 3 times as high as that for 
non-Indigenous children (Bower et al. 2000; Harris & Bucens 2003). The published rates in 
Australia are lower than those reported in the United States of America where between 1 and 
1.5 per 1,000 children have been estimated to be FAS affected, with rates reported as being 
5 times as high as those in Australia for African American children and 16 times as high for 
American Indian children (Sokol et al. 2003).   
In Australia, there is no dedicated national data collection for FASD that provides 
information about this group of disorders.   
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Diagnosis of FASD 
The classification and description of FASD was first formalised by the Institute of Medicine 
in 1996, citing 4 conditions (Stratton et al. 1996). A simplified description of each of these 
conditions follows: 
• Children with FAS have distinct facial characteristics (Figure 1.1), together with evidence 
of growth retardation and neuro-developmental abnormality of the brain. 
• Those with pFAS have one or more of the FAS facial features, along with growth 
retardation and/or developmental abnormality of the brain. 
• ARND children show characteristic behavioural and cognitive impairments but without 
any obvious FAS facial features. 
• ARBD is a specific group of congenital anomalies but without any obvious FAS facial 
features.  
Aetiology of FASD 
Maternal alcohol consumption in pregnancy is considered to be the primary risk factor for 
the development of FASD. There may, however, be other risk factors that are contributing 
causes to the development of individual FASD conditions that are not yet fully understood. 
Individuals with FASD show marked variation in facial features and in neurological 
development. Some of this variation may be related to alcohol intake patterns or other 
lifestyle choices of the mother. Other agents that may disturb the development of an embryo 
or fetus (referred to as teratogens) may also play a role (Anthony et al. 2010). Existing 
research shows that while alcohol exposure during fetal development is a prerequisite for the 
development of FASD, the effects of alcohol exposure can be modified by maternal 
metabolism of alcohol, nutrition, maternal and fetal genetics, and maternal age (Chasnoff 
1985; Streissguth & Dehaene 1993; Warren & Li 2005). 
 4 Fetal Alcohol Spectrum Disorders: strategies to address information gaps 
2 Review of current data collections 
A review of Australian data collections and sources holding FASD-relevant information was 
undertaken. Suitable data collections were identified from the literature and published 
reports.  
Methodology 
A two-step approach was taken to obtain information about data collections. Firstly, 
information about collections was obtained from the published and grey literature; then 
further information was sought from data custodians and project managers. A data 
collection statement was used to assess the features of each of the collections in a 
standardised format. Data items relevant to FASD in these collections were then identified 
using an electronic FASD checklist instrument. In the absence of diagnosis data on one or 
more FASD conditions, an overall assessment of relevant collections was made against the 
following five features common to one or more FASD conditions: 
• fetal alcohol exposure 
• facial anomalies  
• growth retardation  
• neuro-developmental problems 
• birth defects.  
Data collections reviewed 
A total of 20 collections were reviewed and assessed for content relevant to FASD. The 
following collections contained some relevant information: 
• The Australian Paediatric Surveillance Unit collection, based on information provided by 
paediatricians, was the most relevant collection. It contained information on all domains 
of alcohol exposure: facial features, growth retardation, neuro-developmental disorders 
and birth defects. However, this collection was time limited to the period from January 
2001 to December 2004 and restricted to a diagnosis of FAS, the most severe form of 
FASD. This resulted in under-ascertainment of FASD. 
• The Bettering the Evaluation and Care of Health survey collects a rolling set of 
health-related information from a sample of general practitioners, including information 
about alcohol use in pregnancy. The survey, however, does not collect information about 
the woman’s children so as to relate this to a potential or definitive FASD diagnosis. 
• The perinatal collections (national, state and territory) contain some FASD-related 
information, in particular about maternal use of alcohol and fetal growth retardation. In 
addition, all perinatal collections include data on birthweight for gestational age (a 
widely used proxy measure of fetal growth), and further anthropometric information is 
obtained by some of the jurisdictional collections. 
• The congenital anomalies data (national, state and territory) includes reports of problems 
evident at birth, including facial features. The collections use the International Statistical 
Classification of Diseases, 9th Revision, British Paediatric Association (ICD-9-BPA)/ 
International Statistical Classification of Diseases and Related Health Problems,  
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10th Revision, Australian Modification (ICD-10-AM) codes to flag various anomalies. 
However, there is no information available about maternal consumption of alcohol 
during pregnancy in these collections. Any FASD-type symptoms and anomalies 
therefore cannot be flagged as FASD. 
• The National Aboriginal and Torres Strait Islander Social Survey monitors changes in  
social circumstances, including health, of Indigenous Australians. Some limited 
information about alcohol use in pregnancy by Indigenous women is available through 
this survey; however, it provides no information on FASD. 
• Footprints in Time: longitudinal study of Indigenous children provides high-quality 
quantitative and qualitative data that will help to monitor the gap in life circumstances 
of Indigenous and non-Indigenous children. Information is collected about antenatal 
care and health risk behaviours such as smoking and alcohol consumption during 
pregnancy. 
• The Healthy for Life program is aimed at improving the health of Aboriginal and Torres 
Strait Islander mothers, babies and children. It is focused on improving the capacity of 
Indigenous primary health-care services, in particular maternal and child health services 
and chronic diseases care. The collection contains information about alcohol use by 
Indigenous mothers during pregnancy. 
• The National Drug Strategy Household Survey, a cross-sectional survey of people aged 
12 years or older living in private dwellings in Australia, includes specific questions on 
alcohol use in pregnancy. This information can provide population-based information 
that can be used to validate other data to determine alcohol use in pregnancy nationally. 
• The National Hospital Morbidity Database, an ongoing collection, contains information 
about growth retardation, neuro-developmental disorders and birth defects as well as 
information related to the mother who may be admitted due to alcohol-related illnesses 
or conditions. The information, however, relates to the extreme end of the spectrum of 
various conditions, and therefore may lack the sensitivity to detect many cases of FASD 
in the community.  
In summary, no single collection or combination of data sets was fit for purpose. No data 
collection contained definitive FASD diagnoses other than FAS and pFAS. The range and 
quality of available information relevant to FASD varied. While some collections could 
provide relevant FASD data following data enhancements, others have the potential to 
provide certain supplementary and contextual information. 
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3 Models for developing FASD data 
Based on the assessment of the content and quality of various collections, the need for 
regular surveillance and monitoring, and consideration at a national workshop of various 
stakeholders, a number of options were developed by the Expert Advisory Group. These 
were:  
• record linkage 
• time-limited new collection 
• enhancement of congenital anomalies collections. 
Record linkage 
FASD conditions arise during pregnancy; however, they are more often diagnosed in 
childhood. FASD can impact on many interrelated services including health, education, 
justice and social services. Developing effective surveillance and monitoring will require 
information at different life stages and services. Record linkage has a central place in 
developing FASD-related information but it could never serve as the primary source of 
FASD data. Rather, data from notifications of FASD diagnosis by health professionals need 
to be able to be linked with other collections, such as those for health, education and justice. 
This approach could facilitate the production of a longitudinal profile of the health and 
intellectual development of persons with FASD. 
Strategies for facilitating data linkage are critical to the successful use of FASD data. These 
include incorporating statistical linkage keys into data collections across health, education, 
justice and social services and developing strong governance arrangements for the use of 
data and the protection of privacy. 
Time-limited new collection 
One option to increase knowledge about FASD and to help monitor the incidence and 
prevalence of FASD is to develop a time-limited clinical register of FASD cases and use this 
in conjunction with data linkage. This approach would support research in this field, 
including the development of the diagnostic and screening instrument. Once available, the 
instrument would need to be promoted to health professionals nationally. 
A register could provide a short-term repository for clinical notifications of FAS, pFAS, 
ARND and ARBD conditions. It could enable analysis of demographic distribution and other 
information with the potential for assessing the magnitude of the syndrome and the 
development of intervention and management programs.  
However, registers are expensive and resource intensive to establish. A more sustainable 
approach may be to embed registers within the congenital anomalies register in each 
jurisdiction. 
Enhancement of congenital anomalies registers 
Using jurisdictional congenital conditions/anomalies registries to accommodate notifications 
would make use of existing resources and infrastructure. However, some development of 
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jurisdictional congenital anomalies register to accommodate FASD would be required. The 
scope of these collections would need to be extended to cover notifications for children from 
birth up to the age of 7. This would require enhancing some of the current jurisdictional 
registers where there is no, or only limited, facility for notifications after the newborn period.  
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4 Strategies to address gaps in FASD 
information 
Data development to address critical data gaps is a priority before a national FASD data 
collection could be established. These data gaps include the absence of a national definition 
of FASD and nationally agreed guidelines for screening and diagnoses, the lack of specific 
coding for FASD conditions, and limited collection of information on alcohol use during 
pregnancy. 
Development of diagnostic criteria for FASD 
Currently in Australia, there are no screening, diagnostic or treatment services for FASD and 
no national guidelines for screening and diagnosing FASD. Doctors may miss or lack 
knowledge of key clinical criteria to make a FASD diagnosis. Theoretically, all children 
should have an equal chance of being diagnosed with FASD through population screening at 
birth or in early childhood to ensure that all those at risk are clinically assessed. 
The Australian Government announced on 25 June 2014 that it will provide $9.2 million to 
the National FASD Action Plan (Department of Health, 2014). The funding includes $3.1 
million for grants to drug and alcohol services to support alcohol dependent women; up to 
$1.5 million in targeted grants to undertake further research to develop best practice 
guidelines; an additional $4 million to the New Directions: Mother and Babies program; and 
$100,000 to establish the FASD Technical Network. An investment of $500,000 will support 
the finalisation of the National FASD Diagnostic Tool. It is essential that the standards for the 
diagnosis of various FASD conditions are accepted by paediatricians and incorporated into 
clinical practice. Endorsement by the Royal Australasian College of Physicians: Paediatrics 
and Child Health Division would facilitate this process. 
The Australian FASD Collaboration, through the Telethon Institute for Child Health 
Research, conducted the Alcohol, Pregnancy & FASD project during 2010-2012. The aim of 
this project was to develop a diagnostic instrument that consists of a set of tests and 
measurements that could be used to diagnose FASD in Australia. The development of 
diagnostic guidelines for Australia was informed by an evaluation of health professionals’ 
assessment of diagnostic instruments used in other countries (Watkins et al. 2012). A key 
message from this work was that national guidelines in Australia should incorporate 
elements of the University of Washington diagnostic criteria, but that further work would be 
needed to develop guidelines suitable for Australian populations.  
Improving clinical diagnosis of FASD 
Once FASD conditions are diagnosed, this information needs to be captured in data 
collections. An issue affecting the effective surveillance of FASD is the lack of specific coding 
for FASD conditions, apart from FAS (Q86.0) in the current version of  
ICD-10-AM. Consequently, none of the other conditions can be captured in routine data 
collections that rely on ICD-10-AM for diagnostic coding, such as the jurisdictional admitted 
patient collections or the National Hospital Morbidity Database. 
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Monitoring maternal alcohol use  
Despite the recommendation of the National Health and Medical Research Council not to 
consume alcohol while pregnant, over 47% of women in Australia continue to do so (AIHW 
2014). Monitoring patterns of alcohol consumption in pregnancy using validated screening 
tools provides an indirect view of the extent of FASD and is a requirement for diagnosis of 
FASD conditions in the Canadian guidelines (Chudley 2008). Screening tools for alcohol 
consumption in pregnancy have been reviewed in Australia and there are strong arguments 
for introducing them into routine antenatal care (Muggli et al. 2010).  
The national collection of information on alcohol use during pregnancy is a priority area for 
the Council of Australian Governments (COAG 2008). A project for the National Perinatal 
Data Collection drafted standardised data elements that could be used in conjunction with 
validated screening tools to produce consistent national data about alcohol use in pregnancy. 
A pilot study is needed to progress the development of these data elements and to validate 
the instrument before use with other collections. It is also necessary that stakeholders agree 
on the instrument's use, interpretation and acceptability. 
In 2012, an inquiry into the prevention, diagnosis and management of FASD recommended 
that the Australian Government establish mechanisms for clinicians to record women’s 
alcohol consumption during pregnancy so as to ensure that this information is recorded in 
perinatal data collections or notifications throughout Australia (House of Representatives 
Standing Committee on Social Policy and Legal Affairs 2012). 
Box 1 summarises the recommended strategies to address the data gaps. 
Box 1: Strategies to address data gaps 
 Development of a diagnostic tool to nationally standardise diagnosis of FASD. 
 Endorsement of the standard by the Paediatrics and Child Health Division of the Royal 
Australasian College of Physicians. 
 National implementation of standard practice by paediatricians, and by community 
and child health development clinics and other sectors, as appropriate.  
 Incorporation of all FASD conditions in ICD-10-AM and in other classification systems, 
as appropriate.  
 Incorporation of reporting of FASD in routinely collected information systems 
including those for health, education, families and community services, corrections 
and disability services. 
 Monitoring and recording of maternal alcohol use. 
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5 The way forward  
Developing a repository of FASD related data would provide prevalence and demographic 
data to enable further research and directed prevention strategies to be initiated and 
delivered. A national data repository on FASD would also allow appropriate resources and 
services to be delivered to those affected, and their families.  
Data development 
Strategies for developing a national FASD data collection are predicated on the recognised 
critical diagnostic and health information gaps being addressed. These include having a 
national definition of FASD, a nationally standardised FASD diagnostic instrument and 
nationally mandated collection of information on alcohol use during pregnancy. Once 
nationally agreed FASD diagnostic and notification practices are established, ongoing 
surveillance could start. 
National data collection 
Establishing a condition-specific register is resource intensive. A more sustainable approach 
is to build on the existing infrastructure and embed FASD registers within each jurisdiction’s 
congenital anomalies/conditions register. 
A register could provide a repository for clinical notifications of FAS, pFAS and ARND 
conditions. It could also enable demographic distribution and other valuable information to 
be analysed, with the potential for assessing the magnitude of the disease and developing 
intervention and management programs.   
Further research 
A FASD register embedded into jurisdictional congenital anomalies/conditions register 
would support the research still required in this field. It could also provide a platform for 
assessment during the testing and implementation phases of introducing the diagnostic and 
screening instrument. Further research, facilitated by data linkage to other data collections 
such as disability services, could provide information on outcomes for FASD-affected 
children and provide information on long-term management. 
The aetiology of FASD is complex and still not completely understood. Data collections 
made available to researchers can further our knowledge of the aetiology and assist in 
developing effective programs for prevention. Screening studies with longitudinal follow-up 
in a representative population could add to the evidence base. Periodic studies of this nature 
can also provide validation data.   
The incidence and prevalence of FASD in Australia are currently unknown. Australia is 
lacking in its national approach to recognition, diagnosis and response to FASD. There is no 
cure for FASD, only treatment and prevention. A national data collection would provide 
essential information to researchers, clinicians and policy makers to develop and implement 
an appropriate response to this preventable condition. 
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Fetal alcohol spectrum disorders
Strategies to address information gaps
Fetal Alcohol Spectrum Disorders (FASD) is emerging as 
a public health issue in Australia. Health-care providers 
and policy makers need accurate and timely data in a 
useable format to monitor and prevent FASD.
This bulletin identifies ways to facilitate the collection 
and reporting of FASD-related information in Australia. 
The quality of information available in existing data 
collections is variable and incomplete for ascertaining 
cases of FASD. Regular surveillance and monitoring have 
been identified as priorities for determining incidence 
and prevalence.
